Paper Details

  1. Home
  2. Paper Details

Effects of graphene oxide nanoparticles administration against reserpine-induced neurobehavioral damage and oxidative stress in an animal model of Parkinson's disease.

Author: AssafiAbdeslam, AzzouzAbdelmonaim, GamraniHalima, HaidaMohammed, HejjiLamia, MohamedChraa, OukhribMjid, TamegartLahcen, VillarejoLuis Pérez

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Graphene oxide nanoparticles (GONPs) were investigated for their neuroprotective and antioxidant effects in a reserpine model of Parkinson's disease (PD). GONPs reversed reserpine-induced hypoactivity and reduced neuronal oxidative stress, suggesting their potential as an antioxidant agent in the central nervous system.
Paper Details　
Original Abstract of the Article :
Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by the degeneration of substantia nigra dopaminergic neurons. Many therapeutic strategies were explored for PD with no success. In this study, we investigated the efficacy of graphene oxide nanoparticles (GONPs) using ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.fct.2023.113904

データ提供：米国国立医学図書館（NLM）

Graphene Oxide Nanoparticles: A Potential Oasis for Parkinson's Disease

The world of Parkinson's disease (PD) research is a vast desert, with scientists tirelessly seeking effective treatments for this debilitating neurodegenerative disorder. This study investigates the potential of graphene oxide nanoparticles (GONPs) as a therapeutic agent for PD, using a reserpine model to mimic the disease.

GONPs: A Shield Against Neurodegeneration

The researchers found that GONPs effectively reversed reserpine-induced neurobehavioral deficits and oxidative stress in mice. GONPs protected against dopaminergic neuron damage and reduced the levels of oxidative stress markers in the brain. These findings suggest that GONPs have potential as a neuroprotective agent for PD, offering a glimmer of hope for patients struggling with this debilitating disease.

A New Oasis in the Desert of PD

Imagine a desert oasis where a powerful shield, graphene oxide nanoparticles, protects neurons from the ravages of Parkinson's disease. This research sheds light on the potential of GONPs as a neuroprotective agent, offering hope for a future where PD patients can experience relief from their symptoms and live a more fulfilling life. This discovery is a testament to the perseverance of scientists in their quest to find new ways to combat this debilitating disease.

Dr.Camel's Conclusion

This research offers exciting new possibilities for the treatment of Parkinson's disease. The neuroprotective properties of graphene oxide nanoparticles provide a glimmer of hope for a future where PD patients can experience relief from their symptoms. This discovery is a reminder that even in the vast and challenging desert of PD research, new oases of knowledge and hope continue to emerge.

Date :
  1. Date Completed 2023-07-31
  2. Date Revised 2023-07-31
Further Info :

Pubmed ID

37356558

DOI: Digital Object Identifier

10.1016/j.fct.2023.113904

Related Literature

Article Analysis
・Effects of reserpine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.